Member Info for MattTheBrave

Can't see a post by Miss Womble - has it been deleted for some reason?

....but probably just froth! Still, up 50% from the bottom now!

More than £30m wiped of the market cap, yet cost of losing sums to be more like £10m. Overdone perhaps?

....but huge uncertainty on litigation, with first mention of potential dividend effect. Clearly the latter issue being focused on!! Long road to share price recovery here I fear!!

...shot up 17% overnight at the end of US trading. Not really sure why though...?

Agreed. Very very disappointing. Hard to work out whether this is a market trend or simply the slow acceptance of the products from their new manufacturing plants.

That's the advantage of holding cheap, quality stocks. When the mood changes, everyone's happy top pile into them, and indeed, begin to wonder why they didn't do so sooner.... Still, better late than never....;-).

...in a falling market. Well, it is going to be a bloody big wall, right? ;-)

...trading statement. Ever. Anyone actually any idea what it means?

So, answering my own question, it's owned by the insurance Company, so this does have a direct impact on the shareholder-owned firm. Looks like a potential capital gain across whole of Cala of £400m which would be £200m gain for LGEN if they own 50% (can't find that ownership level confirmed anywhere though). This is just less than 2% of mkt cap, so a nice-to-have, but unlikely to move the share price.

Dinoken - Held directly by the Insurance Company, or held in one of their (probably passive) asset management funds?

Agreed - and they're still selling today by the looks of it!! Thankfully, Aviva's portfolio managers are not the best, so I don't believe this heralds some sort of accurate epiphany regarding AMS!

...that it's not good money after bad!!

Good post mate, thanks. As always, brokers provide some useful info and thinking, but generally best to ignore their price targets (and usually their recco's as well!)

...today, but can't see any news..?

Slightly surprised we didn't see a bit of a share price recovery on this

a software company growing at 30% should be valued at 5x revenues IMO. Hence 3x does not imply 'flawless execution' (again, IMO)

Rachel2 - if revenue growth is 30% plus over the next 5 years, then 20x this years earnings is going to look like an absolute bargain.

I think Skint and Mamba both have a point. Clearly the losses haven't had a big effect on revenue growth, (although this might only be because the weak £ has made up for the shortfall?). However, you don't make an RNS, and talk about a significant effect on margins unless the news is meaningful! For me, I am comforted by the fact that the problems are in the recent acquisitions, which smacks of weak due diligence (hopefully now remedied) rather than ponging management ineptitude. Hence I agree with both that share price hugely over done. I've bought more at 230p, 215p, 210p, £2, and 195p. If it goes to 185p, I'll buy more. I've undertaken similar entry price lowering programs before in different stocks which have worked well!

To be fair, he never said it was a farm...;-)